Fairman Group
CVS icon

Fairman Group’s CVS Health CVS Stock Holding History

Fairman Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$428 Hold
5
– – ﹤0.01% 314
2026
Q2 		$517 Hold
5
– – ﹤0.01% 314
2026
Q1 		$359 Hold
5
– – ﹤0.01% 309
2025
Q4 		$397 Hold
5
– – ﹤0.01% 316
2025
Q3 		$377 Hold
5
– – ﹤0.01% 258
2025
Q2 		$345 Hold
5
– – ﹤0.01% 239
2025
Q1 		$224 Hold
5
– – ﹤0.01% 244
2024
Q4 		$224 Hold
5
– – ﹤0.01% 330
2024
Q3 		$314 Hold
5
– – ﹤0.01% 369
2024
Q2 		$295 Hold
5
– – ﹤0.01% 369
2024
Q1 		$399 Hold
5
– – ﹤0.01% 354
2023
Q4 		$395 Buy
+5
New +$356 ﹤0.01% 354

Other funds holding CVS

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Canoe Financial
Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Fairman Group's CVS Position: Q3 2026 in Review

Fairman Group held its CVS Health (CVS) position steady in Q3 2026 at 5 shares worth $428. The position accounts for ﹤0.01% of the portfolio, ranked #314.

Fairman Group first reported a position in CVS in Q4 2023 and has held it in 12 quarters since. The position peaked at $517 in Q2 2026. 1,001 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Fairman Group held 5 shares of CVS Health worth $428 as of Q3 2026.
  • Fairman Group left its CVS Health share count unchanged in Q3 2026.
  • CVS Health made up ﹤0.01% of Fairman Group's portfolio in Q3 2026, its #314 holding.
  • Fairman Group first reported a position in CVS Health in Q4 2023 and has held it in 12 quarters since.
  • Fairman Group's CVS Health position peaked at $517 in Q2 2026.
  • 1,001 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Fairman Group's 13F filing for Q3 2026, filed 26 Oct 2026.